Treatment

Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Beer discusses mCRPC including the AFFINITY trial, AA plus prednisone and ipilimumab from the 2013 ASCO annual meeting.
Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Petrylak discusses trials in mCRPC: PSMA ADC; model for predicting OS; second-line therapy aflibercept vs placebo with dtx/predfrom the 2013 ASCO annual meeting.
Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Sartor discusses outcomes from ALSYMPCA and analysis of dtx on sipuleucel-T in PROCEED patients from the 2013 ASCO annual meeting.
Expert Opinion published on June 28, 2013 in Basic facts
Dr. Tomasz Beer discusses the role of diet in prostate cancer.
Expert Opinion published on June 28, 2013 in Treatment
Dr. Oliver Sartor discusses the new treatments that are now available for prostate cancer
Expert Opinion published on June 28, 2013 in Basic facts
Dr. Daniel Petrylak discusses the most prevalent risk factors in developing prostate cancer.
Expert Opinion published on June 28, 2013 in Diagnosis & Screening
Dr. Tomasz Beer discusses the meaning of staging for prostate cancer and the impact that stage has on treatment.
Expert Opinion published on June 28, 2013 in Treatment
Dr. Daniel Petrylak addresses prostate cancer and bone-related events.
Expert Opinion published on June 28, 2013 in Treatment
Dr Oliver Sartor discusses switching therapy to a new treatment.
Expert Opinion published on June 28, 2013 in Basic facts
Dr. Tomasz Beer discusses MRI use with prostate cancer.